Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards recall — FDA D-0313-2025
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
Overview of recall records associated with ASEGUA THERAPEUTICS LLC, including dates, categories and classifications where available.
Classification mix: Class II: 1.
Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.
This page summarizes recall records in which the official source identifies ASEGUA THERAPEUTICS LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.